PH first vaccine plant to rise in Batangas

Philippine Tribune
Philippine Tribune
GLOVAX PHOTO.jpg
GROUNDBREAKING OF THE FIRST VACCINE PLANT IN THE PHILIPPINES – National Development Co. (NDC) and Glovax Lifescience Corp., a partnership between South Korea’s EuBiologics Corp. and Filipino firm Glovax Lifescience, are establising the country’s first vaccine manufacturing project, estimated to cost between P6 billion to P7.5 billion. The co-investors hold a groundbreaking ceremony last Sept. 27,  2023 in Taysan, Batangas. Shown in photo (L-R) are Duke Lee, international sales manager LG Chem; Seok Kyu Kim, director Business Development EuBiologics Corp; Dr. Geraldine Alingog, medical director Glovax Lifescience; Undersecretary Alessandro O. Sales of Department of Energy, Board of Director of NDC;  Giovanni Alingog, chairman & CEO Glovax Lifescience; Undersecretary Antonilo Mauricio, NDC; Gov.  Hermilando Mandanas Batangas Governor; Laurence Lau, Impact Investment Exchange (IIX) Singapore; Phillip Alpajora, Director & VP for Business Development, Glovax Lifescience; Robert Nuval Baffrey Head, Business Development Makati Development Corp.; and, Bobby Fondevilla, director Board of Investments. 

State-owned National Development Co. (NDC) and Glovax Lifescience Corp., a partnership between South Korea’s EuBiologics Corp. and Filipino firm Glovax Lifescience, are co-investing for the establishment of the country’s first vaccine manufacturing project, estimated to cost between P6 billion to P7.5 billion. 

On hand to witness this historic event were various key participants and stakeholders in the project; including NDC’s General Manager Anton Mauricio and his entire management team and former NDC  General Manager Ditas Rebueno as the investment plan started under her term. 

In his speech, General Manager Antonilo Mauricio personally narrated how his bout with the Covid virus during the pandemic illustrated how the country could have been better served with its own vaccine manufacturing facility, and how the NDC remains committed to supporting Glovax Lifescience Corp. as a minority co-investor. 

Mauricio cited the Glovax Vaccine Plant in Taysan, Batangas as emblematic of what NDC pursues in its investment objectives as NDC envisions a world-class plant in the country and how the vaccine manufacturing plant would help contribute to the country’s national health security and reduce dependence on vaccine importation. (Bernie Cahiles-Magkilat)

Leave a comment